mRNA Victoria Research Acceleration Fund

This program aims to support and accelerate RNA-based therapeutics research in Victoria.
Closes in 4 days

Closing date: Friday 15 December 2023 Fri 15 Dec 2023

What do you get?

Funding varies.

Who is this for?

Organisations growing mRNA capability in Victoria.


There are 2 tiers of funding available:

Tier 1 – Early stage

  • supports early stage RNA-based therapeutic research projects, including discovery, early-stage and pre-clinical research
  • funding of up to $100,000 (GST exclusive).

Tier 2 – Fast track

  • for RNA-based therapeutics projects that can demonstrate a clear pathway to translation and can secure development and commercialisation opportunities
  • funding of up to $500,000 (GST exclusive).

Check if you can apply

Applicants must be one of the following entity types:

  • an incorporated company registered with the Australian Securities and Investment Commission
  • an incorporated association
  • education body
  • public health service
  • other incorporated entity approved by the agency.

Additionally, applicants must:

  • hold an active Australian business number (ABN)
  • have appropriate insurance policies
  • comply with any co-contribution requirements
  • spend the majority of the grant funding in Victoria
  • predominantly conduct and lead the research activities in Victoria.

Apply now

Apply for the mRNA Victoria Research Acceleration Fund

Find out more about your eligibility and how to apply.

Learn how to apply

Contact information